5-amino-1mq human clinical trials benefits of 5-amino-1mq trial GLP-3R Peptide 5-Amino-1MQ NNMT Inhibitor for Research

The cumulative 5-year budget impact demonstrates savings of $14.2 million to the health care system

In humans, intravenous infusion of PP (10 pmol/kg/min) (supra-physiological levels of PP) in ten healthy volunteers (men and women of normal body weight) caused a sustained decrease in both appetite and cumulative 24-hour energy intake by 25.3 +/- 5.8% (193)

This increase in energy levels can be particularly beneficial for individuals on a weight loss program, as it may help to maintain higher levels of physical activity

Researchers studied AOD-9604 to see whether the fat-metabolism part of growth hormone could work without the muscle-building, blood-sugar, and IGF-1 effects of the full hormone